These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cancer heterogeneity and "the struggle for existence": diagnostic and analytical challenges. Horswell S; Matthews N; Swanton C Cancer Lett; 2013 Nov; 340(2):220-6. PubMed ID: 23142290 [TBL] [Abstract][Full Text] [Related]
26. Designing transformative clinical trials in the cancer genome era. Sleijfer S; Bogaerts J; Siu LL J Clin Oncol; 2013 May; 31(15):1834-41. PubMed ID: 23589555 [TBL] [Abstract][Full Text] [Related]
27. Next generation sequencing applications in cancer research. Zhang W; Nykter M; Chen K Cancer Lett; 2013 Nov; 340(2):149-50. PubMed ID: 23764479 [No Abstract] [Full Text] [Related]
28. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer. Liu X; Wang J; Chen L Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794 [TBL] [Abstract][Full Text] [Related]
29. Mutation Profiling of Clinically Advanced Cancers Using Next-Generation Sequencing for Targeted Therapy: A Lifespan Experience. Friedman K; Resnick MB; Safran H R I Med J (2013); 2015 Oct; 98(10):16-20. PubMed ID: 26422540 [TBL] [Abstract][Full Text] [Related]
30. Clinical cancer genome and precision medicine. Roukos DH; Ku CS Ann Surg Oncol; 2012 Nov; 19(12):3646-50. PubMed ID: 22851046 [TBL] [Abstract][Full Text] [Related]
31. ICO amplicon NGS data analysis: a Web tool for variant detection in common high-risk hereditary cancer genes analyzed by amplicon GS Junior next-generation sequencing. Lopez-Doriga A; Feliubadaló L; Menéndez M; Lopez-Doriga S; Morón-Duran FD; del Valle J; Tornero E; Montes E; Cuesta R; Campos O; Gómez C; Pineda M; González S; Moreno V; Capellá G; Lázaro C Hum Mutat; 2014 Mar; 35(3):271-7. PubMed ID: 24227591 [TBL] [Abstract][Full Text] [Related]
32. Clinical cancer genomics: how soon is now? Taylor BS; Ladanyi M J Pathol; 2011 Jan; 223(2):318-26. PubMed ID: 21125684 [TBL] [Abstract][Full Text] [Related]
33. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. Wang E; Zaman N; Mcgee S; Milanese JS; Masoudi-Nejad A; O'Connor-McCourt M Semin Cancer Biol; 2015 Feb; 30():4-12. PubMed ID: 24747696 [TBL] [Abstract][Full Text] [Related]
34. Recent advances and current issues in single-cell sequencing of tumors. Sun HJ; Chen J; Ni B; Yang X; Wu YZ Cancer Lett; 2015 Aug; 365(1):1-10. PubMed ID: 26003306 [TBL] [Abstract][Full Text] [Related]
35. The clinical potential and challenges of sequencing cancer genomes for personalized medical genomics. Cloonan N; Waddell N; Grimmond SM IDrugs; 2010 Nov; 13(11):778-81. PubMed ID: 21046525 [TBL] [Abstract][Full Text] [Related]
37. From genomic landscapes to personalized cancer management-is there a roadmap? Swanton C; Caldas C Ann N Y Acad Sci; 2010 Oct; 1210():34-44. PubMed ID: 20973797 [TBL] [Abstract][Full Text] [Related]
38. Genomic sequencing for cancer diagnosis and therapy. Wang L; Wheeler DA Annu Rev Med; 2014; 65():33-48. PubMed ID: 24274147 [TBL] [Abstract][Full Text] [Related]
39. Targeted therapies of solid cancers: new options, new challenges. Awada A; Aftimos PG Curr Opin Oncol; 2013 May; 25(3):296-304. PubMed ID: 23493191 [TBL] [Abstract][Full Text] [Related]
40. [Human genome sequencing--next generation technology or will the routine sequencing of human genome be possible?]. Pospísilová S; Tichý B; Mayer J Cas Lek Cesk; 2009; 148(7):296-302. PubMed ID: 19642294 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]